Researchers are excited about Retatrutide , a innovative dual agonist showing promising results in initial trials for size reduction . It functions by impacting both pathways : GLP-1 and GIP, that , https://rsaiope691004.amoblog.com/a-new-possibility-for-weight-loss-62807504